Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
mitogen-activated protein kinase kinase kinase 3
(
MEKK3
) is a member of the MAP kinase family whose cellular activity is elevated in response to growth factors, oxidative stress, and hyperosmolar conditions.
MEKK3
regulates MKK3 and MKK5/6/7.
MEKK3
is involved distinctively in the signal pathway for blocking cell proliferation and cell cycle progression, contradictory to the biological responses commonly associated with other members of MEKKs. Based information concerning the substrate specificity of serum- and glucocorticoid-induced kinase 1 (SGK1), R-x-R-x-x-(S/T)-phi, where phi indicates a hydrophobic amino acid, two putative phosphorylation sites (Ser(166) and Ser(337)) were found in
MEKK3
. It was shown that the recombinant
MEKK3
protein and fluorescein-labeled
MEKK3
peptides (FITC-(159)epRsRhlSVi(168) and FITC-(330)dpRgRlpSAd(339)) are phosphorylated by SGK1 in vitro. It was also observed that the intrinsic kinase activity of
MEKK3
on Ser(189) of MKK3 (equivalent to Ser(207) of
MKK6
) decreased along with phosphorylation of Ser(166) and Ser(337) in
MEKK3
in vitro and in vivo. Therefore, it is suggested that SGK1 inhibits
MEKK3
-MKK3/6 signal transduction by phosphorylation of
MEKK3
.
...
PMID:Inhibition of mitogen-activated kinase kinase kinase 3 activity through phosphorylation by the serum- and glucocorticoid-induced kinase 1. 1276 Dec 4
MAPK/ERK kinase kinase 3
(
MEKK3
) is a mitogen-activated protein kinase kinase kinase (MAP3K) that functions upstream of the MAP kinases and IkappaB kinase. Phosphorylation is believed to be a critical component for
MEKK3
-dependent signal transduction, but little is known about the phosphorylation sites of this MAP3K. To address this question, point mutations were introduced in the activation loop (T-loop), substituting alanine for serine or threonine, and the mutants were transfected into HEK293 Epstein-Barr virus nuclear antigen cells.
MEKK3
-dependent activation of an NF-kappaB reporter gene as well as ERK, JNK, and p38 MAP kinases correlated with a requirement for serine at position 526. Constitutively active mutants of
MEKK3
, consisting of S526D and S526E, were capable of activating a NF-kappaB luciferase reporter gene as well as ERK and
MEK
, suggesting that a negative charge at Ser526 was necessary for
MEKK3
activity and implicating Ser526 as a phosphorylation site. An antibody was developed that specifically recognized phospho-Ser526 of
MEKK3
but did not recognize the S526A point mutant. The catalytically inactive (K391M) mutant of
MEKK3
was not phosphorylated at Ser526, indicating that phosphorylation of Ser526 occurs via autophosphorylation. Endogenous
MEKK3
was phosphorylated on Ser526 in response to osmotic stress. In addition, phosphorylation of Ser526 was required for
MKK6
phosphorylation in vitro, whereas dephosphorylation of Ser526 was mediated by protein phosphatase 2A and sensitive to okadaic acid and sodium fluoride. Finally, the association between
MEKK3
and 14-3-3 was dependent on Ser526 and prevented dephosphorylation of Ser526. In summary, Ser526 of
MEKK3
is an autophosphorylation site within the T-loop that is regulated by PP2A and 14-3-3 proteins.
...
PMID:Phosphorylation of serine 526 is required for MEKK3 activity, and association with 14-3-3 blocks dephosphorylation. 1640 1